Market revenue in 2023 | USD 18.3 million |
Market revenue in 2030 | USD 35.8 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Immunotherapy |
Fastest growing segment | Immunotherapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chemotherapy, Immunotherapy, Targeted Therapy |
Key market players worldwide | Eli Lilly and Co, Sanofi SA, Merck & Co Inc, Bristol-Myers Squibb Co, AstraZeneca PLC, Takeda Pharmaceutical Co Ltd, Teva Pharmaceutical Industries Ltd, Roche Holding AG ADR, Clinigen Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to head and neck cancer therapeutics market will help companies and investors design strategic landscapes.
Immunotherapy was the largest segment with a revenue share of 60.11% in 2023. Horizon Databook has segmented the Denmark head and neck cancer therapeutics market based on chemotherapy, immunotherapy, targeted therapy covering the revenue growth of each sub-segment from 2018 to 2030.
The country has more than 160 biotech companies, with 40,000 people employed in this industry, of which more than 5,000 are dedicated R&D employees. There are over 300 biotech service providers, with eight universities and four major university hospitals.
This well-established infrastructure in Denmark allows R&D on anticancer drugs and provides opportunities for the market to expand. In June 2023, FluoGuide A/S, a Demark-based company, announced positive results from stage 2 clinical trials involving head and neck cancer.
The continuing research efforts in the country are expected to provide growth opportunities for the market to expand. The Danish Ministry of Health defines the framework for the national healthcare system.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark head and neck cancer therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Denmark head and neck cancer therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account